Antithrombotic therapy in diabetes: which, when, and for how long?

Ajjan, R.A. orcid.org/0000-0002-1636-3725, Kietsiriroje, N. orcid.org/0000-0002-5076-4450, Badimon, L. et al. (6 more authors) (2021) Antithrombotic therapy in diabetes: which, when, and for how long? European Heart Journal, 42 (23). pp. 2235-2259. ISSN 0195-668X

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© The Author(s) 2021. This is an open access article under the terms of the Creative Commons Attribution License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.

Keywords: Diabetes, Cardiovascular, Cerebrovascular, Peripheral artery disease, Antithrombotic, Antiplatelet
Dates:
  • Published: 14 June 2021
  • Published (online): 25 March 2021
  • Accepted: 23 February 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 Mar 2025 13:25
Last Modified: 05 Mar 2025 13:25
Status: Published
Publisher: Oxford University Press
Identification Number: 10.1093/eurheartj/ehab128
Related URLs:
Sustainable Development Goals:
  • Sustainable Development Goals: Goal 3: Good Health and Well-Being
Open Archives Initiative ID (OAI ID):

Export

Statistics